January 11, 2024
- April 28, 2023 - Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional). See RFA-EB-23-005
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
The purpose of this Notice is to add an additional due date for RFA-EB-23-005, "Research on Bioethical Issues Related to Bionic and Robotic Device Development and Translation (R21 Clinical Trial Optional)."
The following section has been modified to reflect changes to the due date for new applications:
Part 1. Overview Information, Key Dates
Corrected to read (in bold italics):
| Application Due Dates | Review and Award Cycles | ||||
|---|---|---|---|---|---|
| New | Renewal / Resubmission / Revision (as allowed) | AIDS | Scientific Merit Review | Advisory Council Review | Earliest Start Date |
| January 26, 2024 | January 26, 2024 | Not Applicable | July 2024 | October 2024 | December 2024 |
| January 21, 2025 | January 21, 2025 | Not Applicable | July 2025 | October 2025 | December 2025 |
Expiration Date: January 22, 2025
All other aspects of the RFA remain unchanged. These changes are effective immediately.
Moria Bittmann, Ph.D.
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Telephone: 301-496-7699
Email: [email protected]
Lydia Kline, MPH, MA
Office of Science Policy
Email: [email protected]
Telephone: 301-827-9693
and Human Services (HHS)
